Innovent Biologics, Inc. (1801.HK)

HKD 36.2

(-0.82%)

Total Assets Summary of Innovent Biologics, Inc.

Innovent Biologics, Inc.'s latest annual total assets in 2023 was 20.62 Billion CNY , up 17.28% from previous year.
Innovent Biologics, Inc.'s latest quarterly total assets in 2023 FY was 20.62 Billion CNY , up 17.28% from previous quarter.
Innovent Biologics, Inc. reported annual total assets of 17.58 Billion CNY in 2022, up 8.28% from previous year.
Innovent Biologics, Inc. reported annual total assets of 16.24 Billion CNY in 2021, up 37.25% from previous year.
Innovent Biologics, Inc. reported quarterly total assets of 20.62 Billion CNY for 2023 Q4, down 0.0% from previous quarter.
Innovent Biologics, Inc. reported quarterly total assets of 20.62 Billion CNY for 2023 FY, up 17.28% from previous quarter.

Annual Total Assets Chart of Innovent Biologics, Inc. (2023 - 2016)

Historical Annual Total Assets of Innovent Biologics, Inc. (2023 - 2016)

Year	Total Assets	Total Assets Growth
2023	20.62 Billion CNY	17.28%
2022	17.58 Billion CNY	8.28%
2021	16.24 Billion CNY	37.25%
2020	11.83 Billion CNY	63.68%
2019	7.23 Billion CNY	18.29%
2018	6.11 Billion CNY	148.76%
2017	2.45 Billion CNY	-12.73%
2016	2.81 Billion CNY	0.0%

Year	Total Assets	Total Assets Growth
2023 Q2	17.89 Billion CNY	0.0%
2023 Q4	20.62 Billion CNY	0.0%
2023 FY	20.62 Billion CNY	17.28%
2023 Q3	20.62 Billion CNY	15.26%
2023 Q1	17.89 Billion CNY	1.75%
2022 Q1	16.15 Billion CNY	-0.52%
2022 FY	17.58 Billion CNY	8.28%
2022 Q3	17.58 Billion CNY	8.85%
2022 Q2	16.15 Billion CNY	0.0%
2022 Q4	17.58 Billion CNY	0.0%
2021 Q3	16.24 Billion CNY	-1.29%
2021 FY	16.24 Billion CNY	37.25%
2021 Q1	16.45 Billion CNY	39.05%
2021 Q2	16.45 Billion CNY	0.0%
2021 Q4	16.24 Billion CNY	0.0%
2020 Q1	8.95 Billion CNY	23.84%
2020 Q3	11.83 Billion CNY	32.17%
2020 Q2	8.95 Billion CNY	0.0%
2020 Q4	11.83 Billion CNY	0.0%
2020 FY	11.83 Billion CNY	63.68%
2019 FY	7.23 Billion CNY	18.29%
2019 Q4	7.23 Billion CNY	0.0%
2019 Q3	7.23 Billion CNY	29.0%
2019 Q2	5.6 Billion CNY	0.0%
2019 Q1	5.6 Billion CNY	-8.3%
2018 Q1	4.89 Billion CNY	99.16%
2018 Q3	6.11 Billion CNY	24.91%
2018 FY	6.11 Billion CNY	148.76%
2018 Q4	6.11 Billion CNY	0.0%
2018 Q2	4.89 Billion CNY	0.0%
2017 Q3	2.45 Billion CNY	0.0%
2017 Q1	- CNY	0.0%
2017 Q4	2.45 Billion CNY	0.0%
2017 FY	2.45 Billion CNY	-12.73%
2016 FY	2.81 Billion CNY	0.0%

Peer Total Assets Comparison of Innovent Biologics, Inc.

Name	Total Assets	Total Assets Difference
Uni-Bio Science Group Limited	409.99 Million HKD	-4931.162%
CK Life Sciences Int'l., (Holdings) Inc.	11.24 Billion HKD	-83.397%